Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study.

Source:http://linkedlifedata.com/resource/pubmed/id/19352213

Download in:

View as

General Info

PMID
19352213